EVALUATION OF PRESCRIPTIONS OF PHARMACEUTICALS USED TO WEIGHT REDUCTION PREPARED AT COMPOUNDING PHARMACY BEFORE AND AFTER RDC 52/2011

Abstract

The aim of this study was to evaluate prescriptions of pharmaceuticals used to weight loss in a compounding pharmacy
in the city of Pelotas – RS, before and after the term of the Anvisa RDC 52/2011. For this aim, prescriptions containing anorectic drugs were analyzed in the months from January to December in 2010 and 2012. The obtained results showed that women remain the gender that most consume these kind of drugs in both, 2010 and in 2012. In 2010, the most prescribed anorectic were respectively amfepramone (68.7%), femproporex (26.2%), mazindol (2.7%) and sibutramine (2.4%), and the general practitioners were most prevalent physicians prescribing these drugs at both evaluated periods. In 2012, there was a considerable increase in the prescription of sibutramine. However, the validity of the RDC 52/2011 was effective to promote the reduction in prescriptions of anorectic drugs and it is noticeable the importance of regulatory acts on the part of health authorities, regulating the rational use of medicines.